Breakthrough in breast cancer treatment? BriaCell Therapeutics shares soar 150%!

BriaCell Therapeutics Corp., a clinical-stage biotechnology company, saw its shares surge by more than 150% to $1.55 following the release of positive overall survival data ... Read More